Impingement Syndrome Treatment Market Driven by Rising Sports Injuries

Impingement syndrome refers to pain and dysfunction in the shoulder caused by compression or pinching of soft tissues between the humerus bone and the undersurface of the acromion. It commonly affects athletes involved in sports such as swimming, tennis, and baseball where repetitive overhead motions stress the shoulder joint. Treatment for impingement syndrome involves conservative options such as physiotherapy, corticosteroid injections, and non-steroidal anti-inflammatory drugs (NSAIDs) to relieve pain and swelling. For chronic or severe cases, surgical treatment such as arthroscopic shoulder decompression or acromioplasty may be required to enlarge the subacromial space and remove bone spurs.

The global Impingement Syndrome Treatment Market is estimated to be valued at US$ 2,173.5 Mn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
One of the major trends in the impingement syndrome treatment market is the rising demand for minimally invasive surgical procedures. Arthroscopic shoulder surgery has gained popularity as it offers benefits such as less post-operative pain, smaller scars, and faster recovery time compared to open surgeries. Manufacturers are also developing advanced arthroscopic instruments and equipment with improved imaging and maneuverability to facilitate better visualization and treatment of shoulder pathology during minimally invasive procedures. Furthermore, growing awareness about impingement syndrome and its treatment options among athletes and the general population is supporting revenue growth of the market.

Porter’s Analysis
Threat of new entrants: The impingement syndrome market requires large R&D investments and strict regulatory approvals which create high entry barriers for new players.
Bargaining power of buyers: The presence of many established manufacturers gives buyers more bargaining power in this market.
Bargaining power of suppliers: Key raw material suppliers have some bargaining power due to differentiated products and technologies.
Threat of new substitutes: There are limited substitute options for impingement syndrome diagnosis and treatment currently.
Competitive rivalry: The market sees fierce competition between global and local players due to their wide product portfolios.

Key Takeaways

The global impingement syndrome market is expected to witness high growth.

Regional analysis: The impingement syndrome market in North America is expected to dominate other regions owing to increasing development of innovative drugs and devices, rising healthcare expenditure, and presence of major market players in the US and Canada.

Key players: Key players operating in the impingement syndrome market are Thermo Fisher Scientific Inc., GE Healthcare, Merck KGaA, Bio-Rad Laboratories, Inc., Lonza, Abcam plc, PerkinElmer Inc., Bio-Techne, BioVision Inc., Cell Signaling Technology, Inc., and Geno Technology Inc.

*Note: